This is the latest IBS research on our minds this month. Read the highlights or dive deeper.
Can practitioners leverage microbiome insights for weight loss interventions?
‘Should I be taking a probiotic?’ is a simple question with a complex answer, said the researchers behind a microbiome study at the Colorado Clinical and Translational Sciences Institute. Their research delves into the connection between dietary changes and the microbiome, shedding light on how gut microbiota changes may influence metabolism during dietary weight loss interventions.
How researchers are paving the way for gut diagnostics
Rice University engineers in the US developed a breakthrough platform using biosensor bacteria to detect diseases in the gut. These bacteria encased in protective alginate particles thrive in the GI tract, potentially transforming diagnoses like IBD with a faster, less invasive approach. This innovation signals the evolution of diagnostic tools, moving us closer to the practical use of engineered probiotics for in-body disease detection.
Keeping quiet about the burden of bloating
According to a Cedars-Sinai study, about 1 in 7 Americans experience weekly bloating, yet many don't seek medical help. Researchers surveyed almost 90,000 people, with 13.9% reporting bloating within a week of the study. Of those, 58.5% never sought treatment. The study also found women, Latinos, those under 60, and individuals with gastrointestinal issues were more likely to report bloating.